Literature DB >> 4067757

Postoperative morphine infusion in newborn infants: assessment of disposition characteristics and safety.

G Koren, W Butt, H Chinyanga, S Soldin, Y K Tan, K Pape.   

Abstract

Twelve newborn infants were given morphine intravenously for postoperative analgesia. They received a continuous infusion of 6.2 to 40 micrograms/kg/hr for 9 to 105 hours (mean +/- SEM 59.5 +/- 10.2 hours); in four the infusion was preceded by a loading dose of 50 to 100 micrograms/kg. Morphine plasma concentrations correlated with the rate of infusion, but with large variability. There was a tendency for plasma morphine concentrations to decrease in some patients receiving a constant infusion rate, suggesting improvement in morphine clearance rate. Elimination half-life of morphine (13.9 +/- 6.4 hours) was significantly longer than in older children and adults (about 2 hours). Similarly, morphine concentrations in neonates receiving 20 micrograms/kg/hr for 24 hours were three times higher (52 +/- 31 ng/ml) than in older children receiving the same schedule. Two infants who received 32 and 40 micrograms/kg/hr, respectively, developed generalized seizures. Because of the apparently greater sensitivity to morphine and the lower elimination rate in newborn infants, the infused dose should not exceed 15 micrograms/kg/hr.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4067757     DOI: 10.1016/s0022-3476(85)80205-5

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  31 in total

Review 1.  Glucuronidation in humans. Pharmacogenetic and developmental aspects.

Authors:  S N de Wildt; G L Kearns; J S Leeder; J N van den Anker
Journal:  Clin Pharmacokinet       Date:  1999-06       Impact factor: 6.447

2.  Use of sedatives and muscle relaxants in newborn babies receiving mechanical ventilation.

Authors:  M I Levene; M W Quinn
Journal:  Arch Dis Child       Date:  1992-07       Impact factor: 3.791

3.  Fatal outcome with use of rectal morphine for postoperative pain control in an infant.

Authors:  G K Gourlay; R A Boas
Journal:  BMJ       Date:  1992-03-21

Review 4.  Anaesthesia for the neonate.

Authors:  R K Crone; G K Sorensen; R J Orr
Journal:  Can J Anaesth       Date:  1991-05       Impact factor: 5.063

Review 5.  Clinical features, pathogenesis and management of drug-induced seizures.

Authors:  G Zaccara; G C Muscas; A Messori
Journal:  Drug Saf       Date:  1990 Mar-Apr       Impact factor: 5.606

Review 6.  An update on expression and function of P-gp/ABCB1 and BCRP/ABCG2 in the placenta and fetus.

Authors:  Lyrialle W Han; Chunying Gao; Qingcheng Mao
Journal:  Expert Opin Drug Metab Toxicol       Date:  2018-08-03       Impact factor: 4.481

Review 7.  Clinical pharmacokinetics and pharmacodynamics of opioid analgesics in infants and children.

Authors:  K T Olkkola; K Hamunen; E L Maunuksela
Journal:  Clin Pharmacokinet       Date:  1995-05       Impact factor: 6.447

8.  Optimal pain relief in infants and children.

Authors:  F A Burrows; C B Berde
Journal:  BMJ       Date:  1993-10-02

9.  Morphine kinetics after diamorphine infusion in premature neonates.

Authors:  D A Barrett; A C Elias-Jones; N Rutter; P N Shaw; S S Davis
Journal:  Br J Clin Pharmacol       Date:  1991-07       Impact factor: 4.335

Review 10.  Risk-benefit assessment of anaesthetic agents in the puerperium.

Authors:  J Kanto
Journal:  Drug Saf       Date:  1991 Jul-Aug       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.